> Later stage investment is increasingly focused on science
>
> Even five years ago it was incredibly hard to get funding for science-based ventures...
This seems wrong to me.
This may be true for consumer facing products or tech investors like YC, but it misses that biotech investors have been investing $1B+/quarter into science based startups for over a decade now [1]. I suspect that as far as absolute numbers go traditional biotech investing still dominates in this space.
This seems wrong to me.
This may be true for consumer facing products or tech investors like YC, but it misses that biotech investors have been investing $1B+/quarter into science based startups for over a decade now [1]. I suspect that as far as absolute numbers go traditional biotech investing still dominates in this space.
[1] http://www.forbes.com/sites/brucebooth/2015/07/23/the-ventur...